1.888.658.0422Pamela Bourbo, RN,OCN, MPH, CCRC
Manager of Cancer Center Clinical Trials Office
Office: (706) 721-2730
As an academic medical center, the GRU Cancer Center in Augusta, GA is actively involved in cancer research for cancer patients.
Clinical trials are the last step in a carefully regulated, detailed scientific process that starts in a laboratory in cells or tissue and are then tested in humans—oftentimes years later and always after strenuous review.
Medical studies are supervised by a local physician and look at every stage of disease, from first diagnosis to advanced disease. All are designed to find, diagnose, treat or prevent cancer.
- Phase 1 Cancer Clinical Trials (first in man)
- Minority-Based Community Clinical Oncology Program
- Discovery-driven clinical treatments for adult cancer patients affected by all types of cancer
Current Clinical Trial Studies
Minority-Based Community Clinical Oncology Program
Lead by Dr. Sharad Ghamande the Georgia Regents University Minority-Based Community Clinical Oncology Program (GRU MB CCOP) is designed to increase the availability of state-of-the-art cancer treatment and research to minority individuals in their own communities. Establishment of an operational base in this part of Georgia for extending cancer clinical trials and cancer prevention aims to reduce cancer incidence, morbidity, and mortality in minority populations. Learn more
Behavioral, medical and social sciences research at the GRU Cancer Center is conducted to increase understanding of important health and social problems. It's this kind of research, made possible by people who volunteer to participate in innovative studies, that leads to more effective therapies and treatments for disease, and quality-of-life improvements that impact the way we live, work and play.